Il Suk Sohn

Il Suk Sohn

Auto-generated profile, based on publicly available information

Il Suk Sohn

Department of Cardiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2006 in Circulation
Verified
Journal Article
Closed access
HKHae Jin Kee
Hae Jin Kee
ISIl Suk Sohn
Il Suk Sohn
KNKwang-Il Nam
Kwang-Il Nam
JPJong Eun Park
Jong Eun Park
YQYong Ri Qian
Yong Ri Qian
HKHyun Kook
Hyun Kook
Background— A number of distinct stress signaling pathways in myocardium cause cardiac hypertrophy and heart failure. Class II histone deacetylases (HDACs) antagonize several stress-induced pathways and hypertrophy. However, cardiac hypertrophy induced by transgenic overexpression of the homeodomain only protein, HOP, can be prevented by the nonspecific HDAC inhibitors trichostatin A and valproic acid, suggesting that alternate targets that oppose class II HDAC function might exist in myocardium. We tested the effects of several HDAC inhibitors, including a class I HDAC-selective inhibitor, SK-7041, on cardiac hypertrophy induced by angiotensin II (Ang II) treatment or aortic banding (AB). Methods and Results— Cardiac hypertrophy was induced by chronic infusion of Ang II or by AB in mice or rats and evaluated by determining the ratio of heart weight to body weight or to tibia length, cross-sectional area, or echocardiogram. Cardiac hypertrophy induced by Ang II or AB for 2 weeks was significantly reduced by simultaneous administration of trichostatin A, valproic acid, or SK-7041. Echocardiogram revealed that exaggerated left ventricular systolic dimensions were relieved by HDAC inhibitors. HDAC inhibitors partially reversed preestablished cardiac hypertrophy and improved survival of AB mice. The expressions of atrial natriuretic factor, α-tubulin, β-myosin heavy chain, and interstitial fibrosis were reduced by HDAC inhibition. Conclusions— These results suggest that the predominant effect of HDAC inhibition, mainly mediated by class I HDACs, is to prevent cardiac hypertrophy in response to a broad range of agonist and stretch stimuli.

1 July 2007 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
YKYong Sook Kim
Yong Sook Kim
YAYoungkeun Ahn
Youngkeun Ahn
MHMoon Hwa Bs Hong
Moon Hwa Bs Hong
SJSoo Yeon Bs Joo
Soo Yeon Bs Joo
KKKye Hun Kim
Kye Hun Kim
JKJung Chaee Kang
Jung Chaee Kang
Curcumin, a yellow pigment of turmeric in curry, is reported to interfere with nuclear factor (NF)-κB. This study was designed to investigate the underlying pathway of antiinflammation of curcumin on endothelial cells. Human umbilical vein endothelial cells (HUVECs) were stimulated with 10 ng/mL tumor necrosis factor (TNF)-α. Curcumin blocked the activation of NF-κB by TNF-α. Curcumin also reduced the intracellular reactive oxygen species (ROS), monocyte adhesion, phosphorylation of c-Jun N-terminal kinase (JNK), p38, and signal transducer and activator of transcription (STAT)-3 in TNF-α-stimulated HUVECs. The expression of intracellular cell adhesion molecule (ICAM)-1, monocyte chemoattractant protein (MCP)-1, and interleukin (IL)-8 were attenuated by curcumin at both mRNA and protein level. Curcumin, however, did not affect the expression of TNF receptor I and II in TNF-α-stimulated HUVECs. We suggest that curcumin could contribute to protection against the adverse vascular effect of the proinflammatory response through the modulation of p38 and STAT-3 in addition to NF-κB and JNK in endothelial cells.

1 October 2018 in Atherosclerosis
Verified
Journal Article
Closed access
KCKyoung Im Cho
Kyoung Im Cho
ISIchiro Sakuma
Ichiro Sakuma
ISIl Suk Sohn
Il Suk Sohn
SJSang-Ho Jo
Sang-Ho Jo
KKKwang Kon Koh
Kwang Kon Koh

1 October 2018 in Atherosclerosis
Verified
Journal Article
Closed access
JHJi Hye Huh
Ji Hye Huh
DKDae Ryong Kang
Dae Ryong Kang
JJJi-Yun Jang
Ji-Yun Jang
JSJeong-Hun Shin
Jeong-Hun Shin
JKJang Young Kim
Jang Young Kim
KKKwang Kon Koh
Kwang Kon Koh

1 January 2015 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
WCWook-Jin Chung
Wook-Jin Chung
YPYong Bum Park
Yong Bum Park
CJChan Hong Jeon
Chan Hong Jeon
JJJo Won Jung
Jo Won Jung
KKKwang-Phil Ko
Kwang-Phil Ko
In-Jae OhIn-Jae Oh
In-Jae Oh
Chung WJ, et al. J Korean Med Sci. 2015 Oct;30(10):1429-1438. https://doi.org/10.3346/jkms.2015.30.10.1429

1 January 2020 in Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
BSByung Joo Sun
Byung Joo Sun
JPJae-Hyeong Park
Jae-Hyeong Park
MLMinyeong Lee
Minyeong Lee
JCJin-Oh Choi
Jin-Oh Choi
JLJu-Hee Lee
Ju-Hee Lee
SPSeung Woo Park
Seung Woo Park
Sun BJ, et al. J Cardiovasc Imaging. 2019 Sep;28:e42. https://doi.org/10.4250/jcvi.2020.0043